\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes Enhancing EU R&I Horizon EuropeA call for proposals is open for the new recognition prize EU Award for Gender Equality Champions. The prize is meant to:
There are three prize categories:
Candidates can only apply to one of these three categories. Applicants can be a university, higher education institution, or research performing organisation (public or private) located in an EU Member State or a country associated to Horizon Europe.
Deadline for applications is 13 October 2022 at 17.00 (CET). Winners receive a prize of 100.000 euro. In the Sustainable Gender Equality Champions category two winners will be awarded a prize. Winners will be announced before the end of 2022 (HE WIDERA work programme 2021-2022, p.154-156).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
